9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Efficient method for site-directed mutagenesis in large plasmids without subcloning

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Commonly used methods for site-directed DNA mutagenesis require copying the entire target plasmid. These methods allow relatively easy modification of DNA sequences in small plasmids but become less efficient and faithful for large plasmids, necessitating full sequence verification. Introduction of mutations in larger plasmids requires subcloning, a slow and labor-intensive process, especially for multiple mutations. We have developed an efficient DNA mutagenesis technique, UnRestricted Mutagenesis and Cloning (URMAC) that replaces subcloning steps with quick biochemical reactions. URMAC does not suffer from plasmid size constraints and allows simultaneous introduction of multiple mutations. URMAC involves manipulation of only the mutagenesis target site(s), not the entire plasmid being mutagenized, therefore only partial sequence verification is required. Basic URMAC requires two PCR reactions, each followed by a ligation reaction to circularize the product, with an optional third enrichment PCR step followed by a traditional cloning step that requires two restriction sites. Here, we demonstrate URMAC’s speed, accuracy, and efficiency through several examples, creating insertions, deletions or substitutions in plasmids ranging from 2.6 kb to 17 kb without subcloning.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Gene splicing and mutagenesis by PCR-driven overlap extension.

          Extension of overlapping gene segments by PCR is a simple, versatile technique for site-directed mutagenesis and gene splicing. Initial PCRs generate overlapping gene segments that are then used as template DNA for another PCR to create a full-length product. Internal primers generate overlapping, complementary 3' ends on the intermediate segments and introduce nucleotide substitutions, insertions or deletions for site-directed mutagenesis, or for gene splicing, encode the nucleotides found at the junction of adjoining gene segments. Overlapping strands of these intermediate products hybridize at this 3' region in a subsequent PCR and are extended to generate the full-length product amplified by flanking primers that can include restriction enzyme sites for inserting the product into an expression vector for cloning purposes. The highly efficient generation of mutant or chimeric genes by this method can easily be accomplished with standard laboratory reagents in approximately 1 week.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

              About 60% of both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) is due to deletions of the dystrophin gene. For cases with a deletion mutation, the "reading frame" hypothesis predicts that BMD patients produce a semifunctional, internally deleted dystrophin protein, whereas DMD patients produce a severely truncated protein that would be unstable. To test the validity of this theory, we analyzed 258 independent deletions at the DMD/BMD locus. The correlation between phenotype and type of deletion mutation is in agreement with the "reading frame" theory in 92% of cases and is of diagnostic and prognostic significance. The distribution and frequency of deletions spanning the entire locus suggests that many "in-frame" deletions of the dystrophin gene are not detected because the individuals bearing them are either asymptomatic or exhibit non-DMD/non-BMD clinical features.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                2 June 2017
                2017
                : 12
                : 6
                : e0177788
                Affiliations
                [1 ]Center for Vaccines and Immunity, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
                [2 ]First Biotech Inc., Athens, Ohio, United States of America
                [3 ]Heidelberg College, Tiffin, Ohio, United States of America
                [4 ]Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
                [5 ]Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, United States of America
                [6 ]Integrated Biomedical Sciences Graduate Program, The Ohio State University College of Medicine, Columbus, Ohio, United States of America
                University of Helsinki, FINLAND
                Author notes

                Competing Interests: LKH is affiliated with First Biotech Inc as an employee. LKH and MEP are named as inventors in a US Patent on Unrestricted mutagenesis and cloning methods (US patent No. US20110256540 A1. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The URMAC technology is owned by First Biotech Inc., Columbus, OH. For licensing inquiries please contact lhallak@ 123456firstbiotech.com .

                • Conceptualization: LKH.

                • Investigation: LKH KB RK AK.

                • Methodology: LKH MEP AK FM.

                • Writing – original draft: LKH MEP AK FM.

                • Writing – review & editing: LKH MEP FM.

                [¤a]

                Current address: Genetic Counseling Program, College of Medicine, University of Cincinnati and Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, United States of America

                [¤b]

                Current address: Gene Therapy Branch, FDA/CBER/OCTGT/DCGT, Silver Spring, Maryland, United States of America

                [¤c]

                Current address: The Institute of Child Health, University College London, Dubowitz Neuromuscular Centre, London, United Kingdom

                Author information
                http://orcid.org/0000-0001-5169-3626
                Article
                PONE-D-16-51638
                10.1371/journal.pone.0177788
                5456045
                28575024
                006b71c1-6ddd-4a88-a589-1ace714f444a
                © 2017 Hallak et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 31 December 2016
                : 3 May 2017
                Page count
                Figures: 5, Tables: 1, Pages: 15
                Funding
                The URMAC concept, validation, and development including mutagenesis of pUC18 were supported by L.K.H. personal resources. Mutagenesis of pCG-H, pCG-F, RSV replicon, and related research were supported by a National Institutes of Health grant number HL051818 to M.E.P., and by The Research Institute at Nationwide Children’s Hospital. Mutagenesis of the dystrophin cDNA and its related research were done in the F.M. laboratory and supported by the Research Institute at Nationwide Children’s Hospital. R.K. was supported by a T32 grant from the NIH Roadmap Training Program in Clinical Research.
                Categories
                Research Article
                Biology and Life Sciences
                Molecular Biology
                Molecular Biology Techniques
                Artificial Gene Amplification and Extension
                Polymerase Chain Reaction
                Research and Analysis Methods
                Molecular Biology Techniques
                Artificial Gene Amplification and Extension
                Polymerase Chain Reaction
                Biology and Life Sciences
                Genetics
                Mutagenesis
                Biology and life sciences
                Molecular biology
                Molecular biology techniques
                DNA construction
                Plasmid Construction
                Research and analysis methods
                Molecular biology techniques
                DNA construction
                Plasmid Construction
                Biology and life sciences
                Genetics
                DNA
                Forms of DNA
                Circular DNA
                Biology and life sciences
                Biochemistry
                Nucleic acids
                DNA
                Forms of DNA
                Circular DNA
                Biology and life sciences
                Genetics
                DNA
                DNA modification
                Biology and life sciences
                Biochemistry
                Nucleic acids
                DNA
                DNA modification
                Biology and life sciences
                Genetics
                Epigenetics
                DNA modification
                Biology and life sciences
                Genetics
                Gene expression
                DNA modification
                Research and Analysis Methods
                Database and Informatics Methods
                Bioinformatics
                Sequence Analysis
                Sequence Motif Analysis
                Biology and Life Sciences
                Genetics
                Mutation
                Substitution Mutation
                Biology and life sciences
                Genetics
                DNA
                Forms of DNA
                Complementary DNA
                Biology and life sciences
                Biochemistry
                Nucleic acids
                DNA
                Forms of DNA
                Complementary DNA
                Custom metadata
                All relevant data are within the paper.

                Uncategorized
                Uncategorized

                Comments

                Comment on this article